ATE304362T1 - Pharmazeutische zusammensetzung zur stimulierung des wachstums von gram-positiven bazillen und zur erhöhung der azidität der vagina und ihre verwendung - Google Patents

Pharmazeutische zusammensetzung zur stimulierung des wachstums von gram-positiven bazillen und zur erhöhung der azidität der vagina und ihre verwendung

Info

Publication number
ATE304362T1
ATE304362T1 AT98955312T AT98955312T ATE304362T1 AT E304362 T1 ATE304362 T1 AT E304362T1 AT 98955312 T AT98955312 T AT 98955312T AT 98955312 T AT98955312 T AT 98955312T AT E304362 T1 ATE304362 T1 AT E304362T1
Authority
AT
Austria
Prior art keywords
gram
vagina
acidity
stimulating
growth
Prior art date
Application number
AT98955312T
Other languages
English (en)
Inventor
Zhongming Zeng
City Shenzhen
Original Assignee
Zhongming Zeng
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Zhongming Zeng filed Critical Zhongming Zeng
Application granted granted Critical
Publication of ATE304362T1 publication Critical patent/ATE304362T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7004—Monosaccharides having only carbon, hydrogen and oxygen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/702—Oligosaccharides, i.e. having three to five saccharide radicals attached to each other by glycosidic linkages
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0034—Urogenital system, e.g. vagina, uterus, cervix, penis, scrotum, urethra, bladder; Personal lubricants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/02—Drugs for genital or sexual disorders; Contraceptives for disorders of the vagina

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Reproductive Health (AREA)
  • Gynecology & Obstetrics (AREA)
  • Urology & Nephrology (AREA)
  • Engineering & Computer Science (AREA)
  • Endocrinology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
AT98955312T 1997-11-24 1998-11-24 Pharmazeutische zusammensetzung zur stimulierung des wachstums von gram-positiven bazillen und zur erhöhung der azidität der vagina und ihre verwendung ATE304362T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CN97122790 1997-11-24
PCT/CN1998/000277 WO1999026635A1 (fr) 1997-11-24 1998-11-24 Formulation pharmaceutique de stimulation de la croissance de bacilles gram positif et d'augmentation de l'acidite du vagin et son utilisation

Publications (1)

Publication Number Publication Date
ATE304362T1 true ATE304362T1 (de) 2005-09-15

Family

ID=5176887

Family Applications (2)

Application Number Title Priority Date Filing Date
AT98955312T ATE304362T1 (de) 1997-11-24 1998-11-24 Pharmazeutische zusammensetzung zur stimulierung des wachstums von gram-positiven bazillen und zur erhöhung der azidität der vagina und ihre verwendung
AT98955313T ATE306274T1 (de) 1997-11-24 1998-11-24 Verwendung von dextrin, stärke oder glykogen zur behandlung von bakterieller vaginosis

Family Applications After (1)

Application Number Title Priority Date Filing Date
AT98955313T ATE306274T1 (de) 1997-11-24 1998-11-24 Verwendung von dextrin, stärke oder glykogen zur behandlung von bakterieller vaginosis

Country Status (7)

Country Link
US (2) US6632796B1 (de)
EP (2) EP1072268B1 (de)
CN (2) CN1120000C (de)
AT (2) ATE304362T1 (de)
AU (2) AU1223099A (de)
DE (2) DE69831609T2 (de)
WO (2) WO1999026635A1 (de)

Families Citing this family (35)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1306141B1 (it) * 1999-05-17 2001-05-30 Giampiero Valletta Composizione per il trattamento del prurito uremico e di forme diprurito non riconducibili a lesioni organiche.
US6964949B2 (en) * 2000-05-24 2005-11-15 Shanghai Jiao Da Onlly Co., Ltd. Pharmaceutical compositions for promoting the growth of gram-positive bacilli and increasing the acidity in the vagina and the use thereof
JP2002113041A (ja) * 2000-10-11 2002-04-16 Uni Charm Corp 皮膚常在菌をコントロールする吸収性物品
US20030017207A1 (en) * 2001-05-01 2003-01-23 Lin Shun Y. Compositions and methods for treating vulvovaginitis and vaginosis
NZ515869A (en) 2001-11-30 2003-09-26 Med Chem Ingredients Ltd Compositions and methods for animal treatment comprising gluco- and isomalto- oligosaccharides
US6589216B1 (en) 2002-02-20 2003-07-08 Abbott Research Group, Inc. Vaginal douches, vaginal douche applicators and methods of vaginal douching
US8118789B2 (en) 2002-02-20 2012-02-21 Abbott Research Group, Inc. Deodorizer devices and systems for controlling perspiration-related body odor
US7270653B2 (en) 2002-02-20 2007-09-18 Abbott Research Group Methods of treating abnormal biological conditions using metal oxides
US20040126369A1 (en) * 2002-12-30 2004-07-01 Richard Payne Delivery of peroxide-generating enzymes to the vaginal tract
WO2004110461A1 (en) * 2003-06-13 2004-12-23 Idh Holding Aps Treatment of symptoms associated with bacterial vaginosis
US8309103B2 (en) * 2004-01-22 2012-11-13 Alparis, S.A. De C.V. Association of fluconazole-tinidazole for the treatment of vaginal infections, its composition, preparation process and usage
US7276486B2 (en) * 2004-03-15 2007-10-02 Kimberly-Clark Worldwide, Inc. Compositions for vaginal treatment
US20050244402A1 (en) * 2004-04-30 2005-11-03 Villanueva Julie M Absorption of pain-causing agents
US20060093675A1 (en) * 2004-10-29 2006-05-04 Mathew Ebmeier Intravaginal treatment of vaginal infections with metronidazole compositions
US7619008B2 (en) * 2004-11-12 2009-11-17 Kimberly-Clark Worldwide, Inc. Xylitol for treatment of vaginal infections
US20060217443A1 (en) * 2005-03-28 2006-09-28 Kimberly-Clark Worldwide, Inc. Method for preventing and/or treating vaginal and vulval infections
US20060223765A1 (en) * 2005-03-30 2006-10-05 Kimberly-Clark Worldwide, Inc. Method for inhibiting and/or treating vaginal infection
CN101175503B (zh) * 2005-04-27 2012-12-12 深圳福诺生物技术有限公司 一种调节并保持***菌群和***酸度正常的组合物与方法
US7786176B2 (en) 2005-07-29 2010-08-31 Kimberly-Clark Worldwide, Inc. Vaginal treatment composition containing xylitol
US7801502B2 (en) * 2006-12-18 2010-09-21 Aai Corporation Method for implementing continuous radio frequency (RF) alignment in advanced electronic warfare (EW) signal stimulation systems
BRPI1006902A2 (pt) 2009-01-23 2016-02-16 Aziende Chimiche Riunte Angelini Francesco A C R A F S P A formulação farmacêutica ou alimentícia de liberação controlada, processo para a produção de uma forma farmacêutica ou alimentícia, sistema de liberação controlada, e, uso de um sistema de liberação controlada
KR101133723B1 (ko) * 2009-10-19 2012-04-09 최원석 소금 및 당을 유효성분으로 함유하는 질염 예방 및 치료용 조성물 및 이의 용도
US8409628B2 (en) 2010-02-04 2013-04-02 Penguin IP Holdings, Inc. Methods and compositions for oxygenation of skin to treat skin disorders
EP2489408A1 (de) 2011-01-13 2012-08-22 Michael Tchirikov Aminosäurezusammensetzung und deren Verwendung zur Behandlung von fetaler Wachstumsrestriktion (IUGR) und zur parenteralen Ernährung von extrem Frühgeborenen
CN103110973A (zh) * 2013-01-24 2013-05-22 量子高科(中国)生物股份有限公司 保护生殖道微生态健康平衡的方法
SG11201607600TA (en) * 2014-03-13 2016-10-28 Singapore Ze&Z Internat Pte Ltd Vaginal composition and use thereof
CN104825946A (zh) * 2015-04-10 2015-08-12 付秀花 一种洁阴洗液及其制备方法
US11129896B2 (en) * 2015-07-20 2021-09-28 Trilogic Pharma Llc Topical formulations and treatments
KR102587444B1 (ko) 2015-09-29 2023-10-11 킴벌리-클라크 월드와이드, 인크. 미생물총의 건강한 균형을 유지하기 위한 상승 조성물
WO2017180174A1 (en) 2016-04-15 2017-10-19 Fairhaven Health, Llc Compositions and methods for maintaining or enhancing homeostasis or function of female lower reproductive tract
RU2748651C2 (ru) 2017-02-28 2021-05-28 Кимберли-Кларк Ворлдвайд, Инк. Синергическая композиция для сохранения здорового баланса микрофлоры
CN109771434A (zh) * 2019-03-07 2019-05-21 江西鼎中科技有限公司 一种治疗***炎的蔗糖和低聚木糖凝胶
GB202018068D0 (en) 2020-11-17 2020-12-30 Ucl Business Ltd Pharmaceutical composition
CN112451472A (zh) * 2020-11-27 2021-03-09 江苏威克斯医疗科技有限公司 一种调节***微生态的组合物及其制备方法
EP4324465A1 (de) * 2022-08-15 2024-02-21 Gedea Biotech AB Verbindungen zur verwendung bei der behandlung einer mikrobiellen infektion im urogenitalsystem

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1390803A (en) * 1972-07-18 1975-04-16 Wootton L W Medicinal tampons and compositions containing lactulose
IT1172185B (it) * 1981-12-21 1987-06-18 Serono Ist Farm Composizione particolarmente per la vande vaginali
EP0458370B1 (de) * 1985-02-08 1995-09-13 Daicel Chemical Industries, Ltd. Gärung zur Gewinnung von d-Milchsäure
JPS61227777A (ja) * 1985-04-02 1986-10-09 Showa Sangyo Kk ビフイズス菌生育活性剤
US5266329A (en) * 1985-10-31 1993-11-30 Kv Pharmaceutical Company Vaginal delivery system
SE8603338D0 (sv) * 1986-08-07 1986-08-07 Bjorn Andersch Medel for behandling av tillstand i slidan
US4837154A (en) * 1987-01-14 1989-06-06 Wisconsin Alumni Research Foundation Selective growth medium for isolation of Mobiluncus from vaginal fluid
DK505488D0 (da) * 1987-12-21 1988-09-09 Bar Shalom Daniel Middel og anvendelse af samme
US5211971A (en) * 1989-10-23 1993-05-18 Unilever Patent Holdings B.V. Lactic acid bacteria cultures supported on an expanded cereal for preparing flavor or aroma material
ATE214592T1 (de) * 1990-12-21 2002-04-15 Felice Bombart Wässrige vaginaldusche und deren anwendung
US5573765A (en) * 1991-02-19 1996-11-12 Mark S. Reinhard Composition and method for treatment of vaginal yeast infections
FR2678166B1 (fr) * 1991-06-27 1993-10-22 Bioeurope Compositions cosmetiques contenant des glucooligosaccharides.
SE9200199L (sv) * 1992-01-24 1993-07-25 Rune Soeremark Farmaceutisk komposition och dess anvaendning
HU212426B (en) * 1992-07-22 1996-06-28 Vepex Kft Process for producing bioactive pharmaceutical compositions
IT1255488B (it) * 1992-08-04 1995-11-06 Angelini Francesco Ist Ricerca Polisaccaridi del glicogeno
CN1039087C (zh) * 1993-12-29 1998-07-15 昆明宏达实业有限总公司 妇科病治疗保健外用药物
DE19503423A1 (de) * 1995-02-03 1996-08-08 Beiersdorf Ag Antiadhäsive Wirkstoffe
JPH11504049A (ja) * 1996-02-14 1999-04-06 ザ、プロクター、エンド、ギャンブル、カンパニー ツツジ科の植物種より由来する物質および乳酸バクテリア成長因子を含む泌尿生殖器および腸の疾患用の組成物
US6165997A (en) * 1997-11-20 2000-12-26 Statens Serum Institut Phospholipids having antimicrobial activity with or without the presence of antimicrobials

Also Published As

Publication number Publication date
EP1072268A4 (de) 2003-09-03
EP1072269A4 (de) 2003-08-27
WO1999026636A1 (fr) 1999-06-03
ATE306274T1 (de) 2005-10-15
EP1072269A1 (de) 2001-01-31
DE69831609D1 (de) 2005-10-20
CN1120000C (zh) 2003-09-03
US6440949B1 (en) 2002-08-27
US6632796B1 (en) 2003-10-14
EP1072268B1 (de) 2005-09-14
CN1271290A (zh) 2000-10-25
DE69831878D1 (de) 2006-02-23
EP1072268A1 (de) 2001-01-31
CN1120001C (zh) 2003-09-03
EP1072269B1 (de) 2005-10-12
WO1999026635A1 (fr) 1999-06-03
DE69831609T2 (de) 2006-02-02
CN1271291A (zh) 2000-10-25
AU1223199A (en) 1999-06-15
AU1223099A (en) 1999-06-15

Similar Documents

Publication Publication Date Title
ATE304362T1 (de) Pharmazeutische zusammensetzung zur stimulierung des wachstums von gram-positiven bazillen und zur erhöhung der azidität der vagina und ihre verwendung
IS7770A (is) Hlutleysandi mótefni gegn GDF-8 og notkun theirra
DE60130017D1 (de) Kombination enthaltend ein mittel zur verminderung von vegf-aktivität und ein mittel zur verminderung von egf-aktivität
IL147271A0 (en) Compounds that bind her2
HUP0105027A2 (hu) N-Heterociklusos vegyületek karbonsavszármazékai és karbonsav-izoszterei és alkalmazásuk
BG101118A (en) Therapeutical compounds
EP1248791A4 (de) Antisens-modulierung der caspase 3 expression
ATE452640T1 (de) Mittel für erkrankungen assoziert mit knochensubstanzverlust
WO2001015715A3 (en) Composition for maintenance of bone or dental health or treatment of bone or dental disorders
HK1057059A1 (en) Recombinant alpha-l-iduronidase, methods for producing and purifying the same and methods for treating diseases caused by deficiencies thereof
CY1107640T1 (el) Μεθοδος για πιστοποιηση παραγοντων για τη θεραπεια διαβητη
DE60030124D1 (de) Hyaluronsäure-ester zur behandlung von normotrophischen hautnarben
DE69328186D1 (de) Zusammensetzung zur behandlung der parkinson-krankheit
DE60313004D1 (de) Alpha-7-nikotinsäure-rezeptoragonisten und statine in kombination
ATE444073T1 (de) Oxalate-abbauende mikroorganismen oder oxalate- abbauende enzyme zur verhütung der oxalate- verwandten krankheiten
BR9909958A (pt) Formulação farmacêutica, respectivos processo de preparação e uso e método de tratamento ou prevenção de distúrbios ósseos
WO2002045742A3 (en) Lipoteichoic acid immunogenic compositions and methods of making and using thereof
WO2003023004A3 (en) Antisense modulation of fibroblast growth factor receptor 3 expression
WO2000058475A3 (en) Streptococcus pneumoniae antigens
WO2001057042A3 (de) 4-pyridyl- und 2,4-pyrimidinyl-substituierte pyrrolderivate und ihre anwendung in der pharmazie
WO2003087325A3 (en) Methods and compositions for preventing and treating microbial infections
WO1999056666A8 (en) The treatment of sexual dysfunction in certain patient groups
ATE307575T1 (de) Zusammensetzung geeignet als nahrungsmittelzusatz und zur anwendung bei darmerkrankungen sowie bei veränderter darmflora
NO991734L (no) Pyrazolinoner for behandling av potensforstyrrelser
DE50014268D1 (de) Zusammensetzung, enthaltend bakterielle antigene, zum vorbeugen und behandeln von allergischen erkrankungen

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties